knowledge
Previous article:
As demand for Covid shots wanes, Moderna seeks its next success
Next article: Fed up with FDA, ALS advocates consider a take
Next article: Fed up with FDA, ALS advocates consider a take
hotspot
focus
-
Neurocrine congenital adrenal hyperplasia trial succeeds
2025-08-23 17:48 -
Vertex non
2025-08-23 17:46 -
What the US credit downgrade means for the economy, your finances
2025-08-23 17:15 -
Physician groups backed by private equity giant lobby on mergers
2025-08-23 17:07 -
David Liu startup to focus on CRISPR delivery
2025-08-23 17:07 -
Micronoma's microbiome cancer diagnostic approach under fire
2025-08-23 16:57